Recommend to a friend

Applying the Evidence on Antifibrotic Agents for IPF

Drs. David J. Lederer and Fernando J. Martinez address the following topics:

How should patients be managed who experience disease progression while on antifibrotic therapy?
Is there enough evidence on mortality with antifibrotic therapy to discuss this with patients?

Friend's Name :
Friend's email :
You may provide a message here that will be included in the emailed recommendation. (2000 Character Max) Characters written:
Your comment